3858 results for «2350»

Filter By

3858 results

Is cusp overlap technique the standard of care?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Douglas Fraser, Darren Mylotte and Steven Yakubov to learn more about the cusp overlap technique, to discover various cases using it, and to know more about the Optimize PRO study and the TVT registry.

Is cusp overlap technique the standard of care?

Timing and indication for PCI in TAVI patients with coronary disease

18 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Dumonteil, Simon Redwood and Marco Barbanti to learn more about the indications for PCI in TAVI patients with coronary disease, to know more about the latest evidence from the ACTIVATION Trial and the RE-ACCESS Study, and to discover some interesting tips...

Timing and indication for PCI in TAVI patients with coronary disease

Treating bicuspid patients, sizing algorithms

18 May 2021 – From EuroPCR 2021

Watch this session presented by Chris Malkin, Sonia Petronio and Amit Segev to learn more about treating bicuspid patients and sizing algorithms.

Treating bicuspid patients, sizing algorithms

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

18 May 2021 – From EuroPCR 2021

Watch this session presented by David Leistner in order to learn about a study investigating the long-term burden of patients with angina in a real world cohort, to understand associations between treatment decisions in the catheter laboratory and follow-up interventions, and to know about the kind and frequency...

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

Is angio-based FFR ready to replace invasive FFR?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.

Is angio-based FFR ready to replace invasive FFR?

The latest on the prevail drug-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.

The latest on the prevail drug-coated balloon

Complex rotational atherectomy

12 May 2021 – From EuroPCR 2021

This session will be useful if you wish to find out more about heavy coronary calcification and wire entrapment, underestimated type A lesion, no-option critical 3 vessel CAD, and more!

EuroPCR 2021 Complex rotational atherectomy

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

18 May 2021 – From EuroPCR 2021

Watch this session presented by Wolfgang Rottbauer in order to learn about the HighLife transseptal mitral valve replacement procedure, to understand the interaction between the devices and the anatomy and to be familiar with upcoming technologies in structural heart procedures.

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

Complete revascularisation in patients with acute myocardial infarction

18 May 2021 – From EuroPCR 2021

Watch this session presented by Piroth Zsolt in order to get a quick update on the latest most significant evidence in physiology guided PCI in patients with acute MI, to have a recommendation from an expert on how this assessment can be implemented today compatibly with a IIa...

Complete revascularisation in patients with acute myocardial infarction

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.

View the recording of this EuroPCR 2021 Session...

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk

Coronary access after TAVI, a growing need

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...

Coronary access after TAVI, a growing need

SFA and popliteal interventions (part 1) - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to review indications, treatment strategies and equipment and to discuss LIVE procedures.

This session was originally presented during EuroPCR 2021.

SFA and popliteal interventions

Cardiovascular Innovation Pipeline: Transcatheter Mitral Replacement Devices

18 May 2021 – From EuroPCR 2021

Mitral regurgitation is a leading cause of valvular heart disease in Western countries. Transcatheter mitral valve replacement (TMVR) has emerged as a potential therapeutic option for patients with severe mitral disease who are at high risk for conventional surgery. Watch these presentations to find out about...

Cardiovascular Innovation Pipeline: Transcatheter Mitral Replacement Devices
Didn’t find what you were looking for?